Search results
Results from the WOW.Com Content Network
Leslie Boyer, director of the VIPER Institute and a member of the team that developed CroFab, collected data on the cost of production and marketing, and found that the largest true cost to payers in the United States was that of the legal, regulatory and hospital activities involved in selling the drug, nearly 75% of the total.
Anavip (stylized as ANAVIP) is the trade name of a snake antivenin indicated for the management of adult and pediatric patients with North American rattlesnake envenomation. [1] [2] [3] As defined by the FDA, the proper name is crotalidae immune F(ab')2 (equine). [4] It is manufactured by Instituto Bioclon for Rare Disease Therapeutics in the ...
Antivenom, also known as antivenin, venom antiserum, and antivenom immunoglobulin, is a specific treatment for envenomation.It is composed of antibodies and used to treat certain venomous bites and stings. [1]
The Cost of Pet Insurance vs. Paying Out-of-Pocket. To understand the value of pet insurance, let's compare the costs: Routine Care: Annual check-up: Up to $250. Bloodwork: Up to $200. X-rays: Up ...
The Instituto Bioclon is located in Mexico City, Mexico and has a Certificación Internacional de Buenas Prácticas de Manufactura (International Certificate for Good Manufacturing Practices) which was granted to Bioclon by the Instituto Nacional de Vigilancia de Alimentos y Medicamentos [], (INVIMA) (National Food and Drug Monitoring Institute), of the Ministry of Health and Social Protection ...
Snake antivenom is a medication made up of antibodies used to treat snake bites by venomous snakes. [1] It is a type of antivenom.. It is a biological product that typically consists of venom neutralizing antibodies derived from a host animal, such as a horse or sheep.
Alejandro Alagón Cano is a Mexican doctor, researcher, professor and academic. He was an active researcher during the development process of the scorpion antivenom Alacramyn and the pit viper antivenom Antivipmyn, both manufactured by Instituto Bioclon in Mexico.
The DA2PPC vaccine protects against the debilitating and deadly disease canine distemper. This disease is a fatal viral illness that causes neurologic dysfunction, pneumonia, nonspecific systemic symptoms such as fever and fatigue, and weight loss, as well as upper respiratory symptoms and diarrhea, poor appetite, and vomiting. [4]